Argus Sees 'Strong Prospects' For Gilead Sciences
March 20, 2015 at 07:15 AM EDT
Argus reaffirmed its Buy rating on Gilead Sciences, Inc. (NASDAQ: GILD) Thursday and maintained a $130 price target on "strong ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.